Maternal prepregnancy obesity is an independent risk factor for frequent wheezing in infants by age 14 months
Stefano Guerra1, Claudio Sartini, Michelle Mendez
1Centre for Research in Environmental Epidemiology, Barcelona, Spain. sguerra@creal.cat
Insights
Maternal obesity during pregnancy increases the risk of frequent infant wheezing by 14 months. This highlights the impact of in utero exposures on early asthma development.
Area of Science:
- Pediatric Health
- Obstetrics
- Epidemiology
Background:
- Maternal prepregnancy obesity is a known risk factor for childhood asthma.
- Early life wheezing phenotypes are critical indicators for potential respiratory issues.
Purpose of the Study:
- To investigate the association between maternal prepregnancy obesity and the risk of wheezing phenotypes in early childhood.
- To determine if maternal obesity influences the incidence of frequent or infrequent wheezing in infants.
Main Methods:
- Utilized data from 1107 mother-child pairs in the INMA birth cohort study.
- Maternal prepregnancy body mass index (BMI) was categorized; child wheezing was assessed via questionnaires up to 14 months.
- Infant weight-for-length z-scores were computed and included as covariates in adjusted models.
Main Results:
- Maternal obesity was significantly associated with an increased risk of frequent wheezing (adjusted RR 4.18, 95% CI 1.55-11.3).
- No significant association was found between maternal obesity and infrequent wheezing (adjusted RR 1.05, 95% CI 0.55-2.01).
- Children of obese mothers had a higher prevalence of frequent wheezing (11.8%) compared to children of normal-weight mothers (3.8%).
Conclusions:
- Maternal prepregnancy obesity is an independent risk factor for frequent infant wheezing by 14 months of age.
- These findings underscore the importance of the in utero environment in shaping offspring's respiratory health and asthma risk.
- Early identification and management of maternal obesity may be crucial for preventing infant respiratory problems.
Background:
Maternal prepregnancy obesity has been linked to the offspring's risk for subsequent asthma. We determined whether maternal obesity is associated with increased risk of wheezing phenotypes early in life.
Methods:
We used data on 1107 mother-child pairs from two birth cohorts from the INMA-INfancia y Medio Ambiente project. Maternal height was measured and prepregnancy weight self-reported at enrolment (on average at 13.7 ± 2 weeks of gestation). Maternal prepregnancy body mass index was categorised as underweight, normal, overweight and obese according to WHO recommendations. Information on child's wheezing was obtained through questionnaires up to the age of 14 (± 1) months. Wheezing was classified as infrequent (<4 reported wheezing episodes) or frequent (≥ 4 episodes). Weight and length of infants were measured by trained study staff at 14.6 (± 1) months of age and weight-for-length z-scores computed.
Results:
Although maternal obesity did not increase the risk of the child to have any or infrequent wheezing, children of obese mothers were more likely to have frequent wheezing than children of normal-weight mothers (11.8% vs. 3.8%; P = 0.002). In fully adjusted multinomial logistic regression models, including infants' weight-for-length z-scores and other covariates, maternal prepregnancy obesity was associated with increased risk of frequent [adjusted relative risk (RR) 4.18, 95% confidence interval (CI) 1.55, 11.3] but not infrequent (RR 1.05 [95% CI 0.55, 2.01]) wheezing in their children.
Conclusions:
Maternal prepregnancy obesity is independently associated with an increased risk of frequent wheezing in the infant by the age of 14 months. These findings add evidence on the potential effects of in utero exposures on asthma-related phenotypes.
Related Concept Videos
Asthma-I: Introduction
Asthma I: Introduction
Obesity
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

